Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 12, Issue 24
|
pp. 25767–25777
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells
Back to article
Figure 3
(3 of 7)
−
100%
+
Figure 3.
Effect of ZnO NPs(Cp/Gem) on A549 apoptosis.
(
A
) Apoptosis is tested by Annexin V-FITC/PI method. (
B
) The protein levels of Caspase3, Caspase 9, and RARP is measured by Western blot.